Extended Data Fig. 1: Study Design. | Nature Medicine

Extended Data Fig. 1: Study Design.

From: Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

Extended Data Fig. 1

HER: Human Epidermal growth factor Receptor; HR: Hormone Receptor; CT: chemotherapy; CGH: comparative genomic hybridization; CNA: copy number alteration; CR: complete remission; PR: partial remision; SD: stable disease; ctDNA: circulating tumor DNA; FFPE: formalin-fixed paraffin-embedded; n: number of patient; R: randomization ratio.

Back to article page